Docsun BioMed Ltd.

We create non-contact medical technology that measures cholesterol, blood pressure, glucose, SPO2, pulse and breathing rates in 15 seconds with 95% accuracy and is close to receiving US FDA clearance.

Our clientele comprises manufacturers and software providers in industries like healthcare, senior care, gym, automobile, aerospace, etc. In 6 months, we have introduced new vital signs parameters like cholesterol and blood sugar into our technology. We estimate a 95% accuracy rate. Due to our robust developments in recent months, UCrest, a leading provider of the most advanced cloud hospital: iMedic, has agreed to integrate the Docsun Non-contact technology with their platform. Because of our various revenue streams from B2B and B2C services, our CAGR is anticipated to be 22% annually.

Today, millions of people around the world lack access to basic medical facilities for a variety of reasons, owing to disparities in the healthcare sector. Visiting hospitals, and clinics for basic vital sign testing is a time-consuming activity. Traditional medical procedures are expensive and rely on invasive, often painful methods. The global spread of COVID-19 has impacted the healthcare industry, resulting in an increase in delayed diagnosis, overloaded hospitals, and medical supply and staffing shortages. At Docsun, we are committed to disrupting these barriers in the healthcare sector.

Our patented non-invasive technology addresses the many problems that persist in the healthcare sector. The capability to detect a user's vitals in less than 15 seconds using only a camera from their digital device without the need to invasively extract blood from the user makes our technology a more time saving, contactless and revolutionary approach of this century. Due to this, we are able to reach a large audience that possesses a smartphone or computer. We aim to spread our Docsun solutions worldwide to make it accessible and inexpensive to those most in need.

Our solutions are available as an SDK, a Doorway terminal, a web application, and a mobile application, all of which can be distributed on-premise or in a hybrid model. Our revenue streams are generated through sales, subscriptions, licensing, leasing, and transaction service fees from our B2B and B2C services.